Americas (WHO region) vs Myanmar: Confirmed cases of RR-/MDR-TB
Americas (WHO region)
6,242
in 2024
Myanmar
2,538
in 2024
Americas (WHO region) rank
11th
Myanmar rank
13th
Confirmed cases of RR-/MDR-TB over time
- Americas (WHO region)
- Myanmar
How they compare
Americas (WHO region) currently reports 6,242 against 2,538 in Myanmar, a difference of 3,704.
That makes Americas (WHO region)'s figure about 2.5 times Myanmar's.
Across all 19 years both countries report, Americas (WHO region) has been ahead every year.
Americas (WHO region) ranks 11th and Myanmar ranks 13th of 11 groups.
Americas (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2,986 | 647.25 | 2,339 | Americas (WHO region) |
| 2010s | 3,942 | 2,337 | 1,606 | Americas (WHO region) |
| 2020s | 5,414 | 2,382 | 3,032 | Americas (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of rr-/mdr-tb, Americas (WHO region) or Myanmar?
- Americas (WHO region), at 6,242 against 2,538 in Myanmar as of 2024.
- What is the difference in confirmed cases of rr-/mdr-tb between Americas (WHO region) and Myanmar?
- 3,704, with Americas (WHO region) ahead.
- How many years of comparable data are there for Americas (WHO region) and Myanmar?
- 19 years are reported by both, from 2006 to 2024.
- How do Americas (WHO region) and Myanmar rank globally for confirmed cases of rr-/mdr-tb?
- Americas (WHO region) ranks 11th and Myanmar ranks 13th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of RR-/MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.